Thermo Fisher to buy molecular diagnostic solutions firm Qiagen for $11.5bn
Qiagen offers life science and molecular diagnostic solutions to over 500,000 customers across the globe
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
04 Mar 20
Qiagen offers life science and molecular diagnostic solutions to over 500,000 customers across the globe
04 Mar 20
The collaboration will make use of Theraxium Oncology, a digital oncology therapeutics platform offered by Voluntis
04 Mar 20
Biodesix is a lung cancer diagnostic solutions company covering the continuum of patient care from early risk classification…
03 Mar 20
The collaboration agreement initially covers two joint clinical studies on liver cancer, involving coordinating investigators from two AP-HP…
03 Mar 20
Longhorn’s PrimeStore MTM is the only FDA Cleared Nucleic Transport Device that inactivates microbes within the device allowing…
02 Mar 20
The virus has been named SARS-CoV2 and the disease caused by the virus has been named ‘Coronavirus Disease…
02 Mar 20
PerkinElmer has been selected as one of the providers of a newborn screening test for PHE’s SCID evaluation…
28 Feb 20
While AnPac Bio's focus has been on cancer risk assessment, AnPac Bio's bio-physical-property based CDA technology has also…
27 Feb 20
Since January QIAGEN has been providing instruments and consumables to support detection of the virus in China and…
27 Feb 20
Imagion is pleased to report it has purchased equipment and supplies and has completed the necessary vendor qualifications…